Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532296NSE Symbol: GLENMARKP/E(TTM):28.26
ISIN Demat:INE935A01035Div & Yield %:0.24EPS(TTM):37.29
Book Value(Rs):651.2259081Market Cap ( Cr.):29742.63Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :      
Share Capital 28.2228.2228.2228.2228.2228.22
Reserves Total 17849.2516710.3714781.2913198.0511913.8710363.22
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds17877.4716738.5914809.5113226.2711942.0910391.44
Secured Loans 0.000.000.000.006.1119.74
Unsecured Loans 3221.223737.703703.993573.763128.372961.33
Total Debt3221.223737.703703.993573.763134.482981.07
Other Liabilities372.58121.32136.61205.6588.512.60
Total Liabilities21471.2720597.6118650.1117005.6815165.0813375.11
APPLICATION OF FUNDS :      
Gross Block 3183.653026.282848.562595.062260.102581.75
Less : Accumulated Depreciation 1437.701273.951126.07983.11846.62882.63
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1745.951752.331722.491611.951413.481699.12
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress172.34109.04131.40200.01286.20419.68
Producing Properties0.000.000.000.000.000.00
Investments 10334.018559.396989.954713.933268.753212.68
Current Assets, Loans & Advances      
Inventories 1090.21951.66762.39837.50911.211111.18
Sundry Debtors 2505.662678.322488.751835.242087.133828.91
Cash and Bank93.7929.6315.7988.26256.48177.38
Loans and Advances 695.51743.311642.201662.891886.33757.78
Total Current Assets4385.184402.934909.124423.895141.155875.25
Less : Current Liabilities and Provisions      
Current Liabilities 2952.142168.391834.311827.481855.861796.56
Provisions 162.52148.49133.11118.45121.7593.20
Total Current Liabilities3114.662316.881967.411945.921977.621889.76
Net Current Assets1270.522086.052941.712477.973163.543985.49
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets1160.251137.471118.721081.341063.231056.45
Deferred Tax Liability213.50214.20265.43276.60351.10395.83
Net Deferred Tax946.75923.27853.29804.74712.13660.62
Other Assets7001.707167.546011.277197.086320.983397.52
Total Assets21471.2620597.6218650.1117005.6815165.0813375.11
Contingent Liabilities3443.303325.063730.174430.593680.944549.60